Similar Medicine Of Macsart CC Tablet 10s
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Macsart CC Tablet 10s
This combination medication is used to manage high blood pressure (hypertension) effectively. Cilnidipine is a calcium channel blocker, Chlorthalidone is a diuretic (water pill), and Telmisartan is an angiotensin receptor blocker (ARB). Together, they help in lowering blood pressure, protecting the heart, and reducing the risk of stroke and heart attack.
How Macsart CC Tablet 10s works
Cilnidipine relaxes and widens blood vessels, improving blood flow. Chlorthalidone removes excess salt and water from the body, reducing blood volume. Telmisartan blocks angiotensin receptors, preventing blood vessel constriction and promoting
How To Use Macsart CC Tablet 10s
- Take this medication as directed by your healthcare provider, usually once daily, preferably at the same time each day, with or without food.
Special Precautions About Macsart CC Tablet 10s
- Consult a doctor if you have kidney or liver disease.
- Inform your doctor if you have a history of electrolyte imbalance.
Benefits Of Macsart CC Tablet 10s
- Effectively lowers high blood pressure.
- Reduces the risk of stroke and heart attack.
Side Effects Of Macsart CC Tablet 10s
- Fatigue
- Nausea
What If I Missed A Dose Of Macsart CC Tablet 10s
- If you miss a dose, take it as soon as you remember.
- If it’s close to your next dose, skip the missed dose and resume your regular schedule.
- Do not double the dose.
Health And Lifestyle
Drug Interaction
- Antidiabetic drugs
Disease Explanation

Hypertension: High blood pressure increases the risk of heart attack, stroke, and kidney problems. Heart Failure: Helps reduce the load on the heart and prevents fluid buildup.
Safety Advice for Macsart CC Tablet 10s
- High risk
- Moderate risk
- Safe
Use with caution; consult your doctor.
Patients with kidney issues should consult their doctor before use.
Written By
Salony Priya
MBA in pharmaceutical management
Content Updated on
Thursday, 7 November, 2024









